Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Renal and urinary tract neoplasms malignant and unspecified
ADR ID BADD_A03737
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10038364
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01966Ropinirole--
BADD_D01971Rosuvastatin0.000026%
BADD_D01978Ruxolitinib0.000137%
BADD_D01992Saxagliptin0.000655%
BADD_D02029Sitagliptin0.000292%
BADD_D02043Sodium iodide i-131--
BADD_D02058Sorafenib0.006369%
BADD_D02100Sunitinib0.082771%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus0.000743%
BADD_D02108Tafluprost0.000107%
BADD_D02111Tamoxifen0.000238%
BADD_D02154Tenofovir0.002908%
BADD_D02236Tofacitinib0.000723%
BADD_D02237Tofacitinib citrate--
BADD_D02252Tositumomab--
BADD_D02272Triamcinolone acetonide--
BADD_D02325Valdecoxib--
BADD_D02330Valrubicin0.000112%
BADD_D02331Valsartan0.002566%
BADD_D02342Vedolizumab--
BADD_D02373Warfarin0.000028%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib0.000241%
BADD_D02412Octreotide0.000186%
BADD_D02434Cinacalcet0.000391%
BADD_D02464Fingolimod0.001567%
BADD_D02470Nintedanib--
BADD_D02487Baricitinib--
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages